LT3431078T - Nepulsatilios prailginto atpalaidavimo betahistino geriamosios kietos kompozicijos - Google Patents

Nepulsatilios prailginto atpalaidavimo betahistino geriamosios kietos kompozicijos

Info

Publication number: LT3431078T
Authority: LT; Lithuania
Prior art keywords: pulsatile; prolonged; solid compositions; oral solid; betahistine
Prior art date: 2017-07-20

Application number

LTEP17189264.9T

Other languages

English (en)

Inventor

Himanshukumar Dasharathlal Patel

Vinod Purushottam Dube

Venkata Ramana Naidu

Sunil Shantwan Borude

Original Assignee

Intas Pharmaceuticals Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-07-20

Filing date

2017-09-04

Publication date

2021-05-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59829185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3431078(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-09-04 Application filed by Intas Pharmaceuticals Limited filed Critical Intas Pharmaceuticals Limited

2021-05-10 Publication of LT3431078T publication Critical patent/LT3431078T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

LTEP17189264.9T 2017-07-20 2017-09-04 Nepulsatilios prailginto atpalaidavimo betahistino geriamosios kietos kompozicijos LT3431078T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN201721025857		2017-07-20

Publications (1)

Publication Number	Publication Date
LT3431078T true LT3431078T (lt)	2021-05-10

Family

ID=59829185

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP17189264.9T LT3431078T (lt)	2017-07-20	2017-09-04	Nepulsatilios prailginto atpalaidavimo betahistino geriamosios kietos kompozicijos

Country Status (22)

Country	Link
US (1)	US11433058B2 (lt)
EP (2)	EP3431078B1 (lt)
JP (1)	JP7084950B2 (lt)
CN (1)	CN110891551A (lt)
AR (1)	AR112281A1 (lt)
AU (1)	AU2018302771B2 (lt)
BR (1)	BR112020000977A2 (lt)
CA (1)	CA3069282A1 (lt)
CL (1)	CL2020000124A1 (lt)
CO (1)	CO2020001742A2 (lt)
DK (1)	DK3431078T3 (lt)
ES (1)	ES2862209T3 (lt)
HR (1)	HRP20210570T1 (lt)
LT (1)	LT3431078T (lt)
MX (1)	MX2020000702A (lt)
PH (1)	PH12020500001A1 (lt)
PL (1)	PL3431078T3 (lt)
PT (1)	PT3431078T (lt)
SA (1)	SA520411067B1 (lt)
UY (1)	UY37798A (lt)
WO (1)	WO2019016668A1 (lt)
ZA (1)	ZA202000030B (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115266955B (zh) *	2021-04-29	2024-10-01	景忠山国药（唐山）有限公司	基于一测多评法的耳聋胶囊中成分含量的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1309591B1 (it) *	1999-03-05	2002-01-24	Formenti Farmaceutici Spa	Composizioni a rilascio controllato di betaistina.
KR20030034171A (ko) *	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	옥시모르폰 제어 방출 제형
TWI319713B (en) *	2002-10-25	2010-01-21		Sustained-release tramadol formulations with 24-hour efficacy
SI1493435T1 (sl) *	2003-07-04	2008-10-31	Formenti Farmaceutici Spa	Betahistinski sestavki s kontroliranim sproĺ äśanjem
WO2012131722A1 (en) *	2011-03-30	2012-10-04	Sun Pharma Advanced Research Company Ltd.	Controlled release composition of betahistine
DE102012105528A1 (de)	2012-06-25	2014-01-02	Hennig Arzneimittel Gmbh & Co. Kg	Arzneiform zur Freisetzung von Wirkstoffen
WO2014174073A1 (en) *	2013-04-26	2014-10-30	Sandoz Ag	Sustained release formulations of tofacitinib

2017
- 2017-09-04 ES ES17189264T patent/ES2862209T3/es active Active
- 2017-09-04 PL PL17189264T patent/PL3431078T3/pl unknown
- 2017-09-04 LT LTEP17189264.9T patent/LT3431078T/lt unknown
- 2017-09-04 DK DK17189264.9T patent/DK3431078T3/da active
- 2017-09-04 PT PT171892649T patent/PT3431078T/pt unknown
- 2017-09-04 EP EP17189264.9A patent/EP3431078B1/en active Active
2018
- 2018-07-05 UY UY0001037798A patent/UY37798A/es not_active Application Discontinuation
- 2018-07-16 US US16/632,500 patent/US11433058B2/en active Active
- 2018-07-16 CN CN201880047204.7A patent/CN110891551A/zh active Pending
- 2018-07-16 EP EP18835809.7A patent/EP3654954A4/en not_active Withdrawn
- 2018-07-16 AU AU2018302771A patent/AU2018302771B2/en active Active
- 2018-07-16 CA CA3069282A patent/CA3069282A1/en active Pending
- 2018-07-16 BR BR112020000977-6A patent/BR112020000977A2/pt unknown
- 2018-07-16 JP JP2019570397A patent/JP7084950B2/ja active Active
- 2018-07-16 WO PCT/IB2018/055233 patent/WO2019016668A1/en active Application Filing
- 2018-07-16 MX MX2020000702A patent/MX2020000702A/es unknown
- 2018-07-19 AR ARP180102029 patent/AR112281A1/es unknown
2020
- 2020-01-02 ZA ZA2020/00030A patent/ZA202000030B/en unknown
- 2020-01-02 PH PH12020500001A patent/PH12020500001A1/en unknown
- 2020-01-16 SA SA520411067A patent/SA520411067B1/ar unknown
- 2020-01-16 CL CL2020000124A patent/CL2020000124A1/es unknown
- 2020-02-14 CO CONC2020/0001742A patent/CO2020001742A2/es unknown
2021
- 2021-04-09 HR HRP20210570TT patent/HRP20210570T1/hr unknown

Also Published As

Publication number	Publication date
SA520411067B1 (ar)	2022-09-28
UY37798A (es)	2019-01-02
US11433058B2 (en)	2022-09-06
ZA202000030B (en)	2021-08-25
ES2862209T3 (es)	2021-10-07
CN110891551A (zh)	2020-03-17
CA3069282A1 (en)	2019-01-24
EP3654954A4 (en)	2021-06-16
HRP20210570T1 (hr)	2021-09-03
JP2020528045A (ja)	2020-09-17
CO2020001742A2 (es)	2020-02-28
CL2020000124A1 (es)	2020-09-21
PL3431078T3 (pl)	2021-07-12
BR112020000977A2 (pt)	2020-07-14
WO2019016668A1 (en)	2019-01-24
AU2018302771A1 (en)	2020-01-16
US20210161871A1 (en)	2021-06-03
DK3431078T3 (da)	2021-04-19
EP3431078B1 (en)	2021-01-20
PH12020500001A1 (en)	2020-09-14
RU2020101925A3 (lt)	2021-08-27
RU2020101925A (ru)	2021-08-20
AR112281A1 (es)	2019-10-09
AU2018302771B2 (en)	2022-05-12
PT3431078T (pt)	2021-04-21
JP7084950B2 (ja)	2022-06-15
EP3654954A1 (en)	2020-05-27
MX2020000702A (es)	2020-10-14
EP3431078A1 (en)	2019-01-23

Publication	Publication Date	Title
ZA201903452B (en)	2023-02-22	Oral care compositions
IL257658B (en)	2022-01-01	compounds for oral care
ZA201903460B (en)	2022-12-21	Oral care compositions
HK1249021A1 (zh)	2018-10-26	牙科組合物
IL259044B (en)	2020-05-31	compounds for oral care
IL257659B (en)	2020-03-31	Oral care compositions
ZA201807771B (en)	2023-04-26	Oral care compositions
ZA201903412B (en)	2020-09-30	Personal care compositions comprising poorly soluble compounds
HK1256500A1 (zh)	2019-09-27	牙科組合物
ZA201903431B (en)	2022-12-21	Oral care compositions
IL271759A (en)	2020-02-27	Pharmaceutical preparations that include anthraxtinib
ZA201807730B (en)	2023-05-31	An oral care composition
ZA201903379B (en)	2022-12-21	Oral care compositions
ZA201706785B (en)	2019-07-31	Oral care compositions
ZA201901982B (en)	2022-12-21	Oral care compositions
ZA201803909B (en)	2023-03-29	Oral care compositions
ZA201903451B (en)	2022-12-21	Oral care compositions
ZA201903430B (en)	2022-07-27	Oral care compositions
ZA201902623B (en)	2022-12-21	Oral care composition
ZA201902622B (en)	2022-12-21	Oral care composition
ZA202004108B (en)	2022-01-26	Oral care composition
ZA202001909B (en)	2023-10-25	Oral care compositions
SG11201708597VA (en)	2017-11-29	Oral care composition
ZA201903378B (en)	2022-12-21	Oral care composition
GB201512023D0 (en)	2015-08-19	Dental compositions